23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › SAMSUNG BIOLOGICS CO. LTD. › 2023-2024

SAMSUNG BIOLOGICS CO. LTD. 2023-2024 Proxy Voting Records

At SAMSUNG BIOLOGICS CO. LTD.'s shareholder meeting held March 15, 2024, in the 2023-2024 proxy season, 55 asset managers reported how they voted in their SEC Form N-PX filings, covering 530 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — Approve Total Remuneration of Inside Directors and Outside Directors — the reporting funds and managers cast 100% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings. Page generated November 8, 2026.

  • 11Reported items
  • 55Asset managers
  • 530Fund votes
  • March 15, 2024Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from SAMSUNG BIOLOGICS CO. LTD. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore SAMSUNG BIOLOGICS CO. LTD. in the interactive database Compare manager voting policies

How asset managers voted at the SAMSUNG BIOLOGICS CO. LTD. 2023-2024 meeting

Each item below shows how the 55 asset managers that disclosed a SAMSUNG BIOLOGICS CO. LTD. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of SAMSUNG BIOLOGICS CO. LTD.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Seo Seung-hwan as Outside Director

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 43 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 42 asset managers voting on “Elect Seo Seung-hwan as Outside Director” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Invesco664,5290 00For
Vanguard452,7260 00For
BlackRock419,1200 00For
Fidelity225,5550 00For
FINANCIAL INVESTORS TRUST155,0000 00For
American Century63,5370 00For
TIAA39,1910 00For
Goldman Sachs27,0250 00For
State Street20,7870 00For
Dimensional19,3880 00For
Pacific Life18,1740 00For
Columbia Threadneedle16,0500 00For
Victory Capital12,2220 00For
Franklin Templeton7,5790 00For
WisdomTree6,5290 00For
Northern Trust5,0960 00For
New York Life5,0490 00For
Thrivent3,8640 00For
WILLIAM BLAIR FUNDS3,5550 00For
Artisan3,4800 00For
DWS3,1930 00For
MATTHEWS INTERNATIONAL FUNDS3,1830 00For
Empower3,0870 00For
MassMutual2,9210 00For
HC CAPITAL TRUST2,1160 00For

Fund voting reports, all 42 managers: 2,193,500 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Elect Seo Seung-hwan as Outside Director” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP369,3140 00For

Institutional-manager reports, all 1 managers: 369,314 for.

2. Elect Seo Seung-hwan as a Member of Audit Committee

No official resultsDIRECTOR ELECTIONSCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: votes by 43 asset managers

The 43 asset managers below reported 2,193,946 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,193,946
Largest asset managers voting on “Elect Seo Seung-hwan as a Member of Audit Committee” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Invesco664,5290 00For
Vanguard452,7260 00For
BlackRock419,1200 00For
Fidelity225,5550 00For
FINANCIAL INVESTORS TRUST155,0000 00For
American Century63,5370 00For
TIAA39,1910 00For
Goldman Sachs27,0250 00For
State Street20,7870 00For
Dimensional19,3880 00For
Pacific Life18,1740 00For
Columbia Threadneedle16,0500 00For
Victory Capital12,2220 00For
Franklin Templeton7,5790 00For
WisdomTree6,5290 00For
Northern Trust5,0960 00For
New York Life5,0490 00For
Thrivent3,8640 00For
WILLIAM BLAIR FUNDS3,5550 00For
Artisan3,4800 00For
DWS3,1930 00For
MATTHEWS INTERNATIONAL FUNDS3,1830 00For
Empower3,0870 00For
MassMutual2,9210 00For
HC CAPITAL TRUST2,1160 00For

Showing the 25 largest of 43 asset managers. All 43 are in the interactive database (link above).

3. ELECTION OF AUDIT COMMITTEE MEMBER: SEO SEUNG HWAN

No official resultsCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: votes by 12 asset managers

The 12 asset managers below reported 69,170 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 69,170
Largest asset managers voting on “ELECTION OF AUDIT COMMITTEE MEMBER: SEO SEUNG HWAN” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab30,7800 00For
JPMorgan13,5550 00For
VanEck Funds8,7500 00For
KOREA FUND INC5,4500 00For
John Hancock4,1020 00For
Jackson National1,9810 00For
SEI1,2990 00For
VanEck VIP Trust1,1600 00For
Morgan Stanley9000 00For
Russell Investments8280 00For
Krane Shares Trust2710 00For
Federated Hermes940 00For

4. Elect SEO Seung Hwan

No official resultsDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 12 asset managers

The 12 asset managers below reported 69,170 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 69,170
Largest asset managers voting on “Elect SEO Seung Hwan” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab30,7800 00For
JPMorgan13,5550 00For
VanEck Funds8,7500 00For
KOREA FUND INC5,4500 00For
John Hancock4,1020 00For
Jackson National1,9810 00For
SEI1,2990 00For
VanEck VIP Trust1,1600 00For
Morgan Stanley9000 00For
Russell Investments8280 00For
Krane Shares Trust2710 00For
Federated Hermes940 00For

5. Approve Financial Statements and Allocation of Income

No official resultsCAPITAL STRUCTURECORPORATE GOVERNANCE

99.0% of fund votes cast · no official result

FOR
Details: votes by 43 asset managers

The 43 asset managers below reported 2,172,985 for, 21,845 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,172,985AGAINST: 21,845
Largest asset managers voting on “Approve Financial Statements and Allocation of Income” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Invesco664,5290 00For
Vanguard452,7260 00For
BlackRock419,1200 00For
Fidelity225,5550 00For
FINANCIAL INVESTORS TRUST155,0000 00For
American Century63,5370 00For
TIAA39,1910 00For
Goldman Sachs27,0250 00For
State Street020,787 00Against
Dimensional19,3880 00For
Pacific Life18,1740 00For
Columbia Threadneedle16,0500 00For
Victory Capital12,2220 00For
Franklin Templeton7,5790 00For
WisdomTree6,5290 00For
Northern Trust5,0960 00For
New York Life5,0490 00For
Thrivent3,8640 00For
WILLIAM BLAIR FUNDS3,5550 00For
Artisan3,4800 00For
DWS3,1930 00For
MATTHEWS INTERNATIONAL FUNDS3,1830 00For
Empower3,0870 00For
MassMutual2,9210 00For
HC CAPITAL TRUST2,1160 00For

Showing the 25 largest of 43 asset managers. All 43 are in the interactive database (link above).

6. Financial Statements and Allocation of Profits/Dividends

No official resultsCAPITAL STRUCTURE

98% of fund votes cast · no official result

FOR
Details: votes by 7 asset managers

The 7 asset managers below reported 42,983 for, 828 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 42,983AGAINST: 828
Largest asset managers voting on “Financial Statements and Allocation of Profits/Dividends” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab30,7800 00For
VanEck Funds8,7500 00For
SEI1,2990 00For
VanEck VIP Trust1,1600 00For
Morgan Stanley9000 00For
Russell Investments0828 00Against
Federated Hermes940 00For

7. Approval of financial statements

98% of fund votes cast · no official result

FOR
Details: description as filed, votes by 5 asset managers

Description as filed by funds: APPROVAL OF FINANCIAL STATEMENTS

The 5 asset managers below reported 24,773 for, 586 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 24,773AGAINST: 586
Largest asset managers voting on “APPROVAL OF FINANCIAL STATEMENTS” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JPMorgan13,5550 00For
KOREA FUND INC5,4500 00For
John Hancock3,516586 00Mixed
Jackson National1,9810 00For
Krane Shares Trust2710 00For

8. Approve Total Remuneration of Inside Directors and Outside Directors

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 44 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 42 asset managers voting on “Approve Total Remuneration of Inside Directors and Outside Directors” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Invesco664,5290 00For
Vanguard452,7260 00For
BlackRock419,1200 00For
Fidelity225,5550 00For
FINANCIAL INVESTORS TRUST155,0000 00For
American Century63,5370 00For
TIAA39,1910 00For
Goldman Sachs27,0250 00For
State Street20,7870 00For
Dimensional19,3880 00For
Pacific Life18,1740 00For
Columbia Threadneedle16,0500 00For
Victory Capital12,2220 00For
Franklin Templeton7,5790 00For
WisdomTree6,5290 00For
Northern Trust5,0960 00For
New York Life5,0490 00For
Thrivent3,8640 00For
WILLIAM BLAIR FUNDS3,5550 00For
Artisan3,4800 00For
DWS3,1930 00For
MATTHEWS INTERNATIONAL FUNDS3,1830 00For
Empower3,0870 00For
MassMutual2,9210 00For
HC CAPITAL TRUST2,1160 00For

Fund voting reports, all 42 managers: 2,193,500 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 2 asset managers voting on “Approve Total Remuneration of Inside Directors and Outside Directors” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
APG Asset Management US Inc.163,2260 00For
RWC Asset Management LLP2,6500 00For

Institutional-manager reports, all 2 managers: 165,876 for.

9. Directors' Fees

Combines 2 wordings of this item as funds reported it.

0.3% of fund votes cast · no official result

AGAINST
Details: votes by 7 asset managers

The 7 asset managers below reported 94 for, 43,717 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 94AGAINST: 43,717
Largest asset managers voting on “Directors' Fees” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab030,780 00Against
VanEck Funds08,750 00Against
SEI01,299 00Against
VanEck VIP Trust01,160 00Against
Morgan Stanley0900 00Against
Russell Investments0828 00Against
Federated Hermes940 00For

10. Approval of remuneration for director

99% of fund votes cast · no official result

FOR
Details: description as filed, votes by 5 asset managers

Description as filed by funds: APPROVAL OF REMUNERATION FOR DIRECTOR

The 5 asset managers below reported 25,088 for, 271 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 25,088AGAINST: 271
Largest asset managers voting on “APPROVAL OF REMUNERATION FOR DIRECTOR” at SAMSUNG BIOLOGICS CO. LTD., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JPMorgan13,5550 00For
KOREA FUND INC5,4500 00For
John Hancock4,1020 00For
Jackson National1,9810 00For
Krane Shares Trust0271 00Against

Showing the 10 reported items with the widest manager coverage, of 11 in total. Every item is in the interactive database (link above).

Largest SAMSUNG BIOLOGICS CO. LTD. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.

Fund voting reports: top SAMSUNG BIOLOGICS CO. LTD. shareholders by shares voted on “Approve Total Remuneration of Inside Directors and Outside Directors”, 2023-2024
#Asset manager Shares voted
1Invesco 664,529
2Vanguard 452,726
3BlackRock 419,120
4Fidelity 225,555
5FINANCIAL INVESTORS TRUST 155,000
6American Century 63,537
7TIAA 39,191
8Goldman Sachs 27,025
9State Street 20,787
10Dimensional 19,388
Institutional-manager reports: top SAMSUNG BIOLOGICS CO. LTD. shareholders by shares voted on “Approve Total Remuneration of Inside Directors and Outside Directors”, 2023-2024
#Asset manager Shares voted
1APG Asset Management US Inc. 163,226
2RWC Asset Management LLP 2,650

Shown as share counts, not percentages: no shares-outstanding figure has been matched to SAMSUNG BIOLOGICS CO. LTD. for the 2023-2024 season, so there is no denominator to divide by.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

SAMSUNG BIOLOGICS CO. LTD. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

proxyvotesnow.com, “SAMSUNG BIOLOGICS CO. LTD. 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/samsung-biologics-co-ltd/2024 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.